Regorafenib cancer drug capsules. This drug, marketed as Stivarga, is a multi-kinase inhibitor used to treat metastatic colorectal cancer, advanced hepatocellular carcinoma and advanced gastrointestinal stromal tumours. It blocks a number of cell signaling molecules (kinases) and prevents cell proliferation and the growth of new blood vessels (angiogenesis) to the cancer. | |
Licence : | Droits gérés |
Crédit: | Science Photo Library / Marazzi, Dr. P. |
Taille de l’image : | 4485 px × 2990 px |
Model Release : | Non requis |
Property Release : | Non requis |
Restrictions : |
|